(NASDAQ: WGS) Genedx Holdings's forecast annual revenue growth rate of 18.17% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 7.01%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.78%.
Genedx Holdings's revenue in 2026 is $454,426,000.On average, 11 Wall Street analysts forecast WGS's revenue for 2026 to be $14,517,911,184, with the lowest WGS revenue forecast at $13,970,071,106, and the highest WGS revenue forecast at $15,164,762,099. On average, 11 Wall Street analysts forecast WGS's revenue for 2027 to be $18,028,620,711, with the lowest WGS revenue forecast at $16,787,406,554, and the highest WGS revenue forecast at $19,614,881,667.
In 2028, WGS is forecast to generate $22,566,120,324 in revenue, with the lowest revenue forecast at $19,394,493,089 and the highest revenue forecast at $27,581,973,495.